3467705

Organization name

Labsystems Diagnostics Oy

SRN

FI-MF-000018281

Manufacturer status

Active

13 warnings recorded — scroll inside the panel to see all entries.

• CW010

  EUDAMED did not publish a description for this code.
• CW057

  EUDAMED did not publish a description for this code.
• CW075

  EUDAMED did not publish a description for this code.
• CW079

  EUDAMED did not publish a description for this code.
• CW087

  EUDAMED did not publish a description for this code.
• CW099

  EUDAMED did not publish a description for this code.
• CW139

  EUDAMED did not publish a description for this code.
• CW150

  EUDAMED did not publish a description for this code.
• CW154

  EUDAMED did not publish a description for this code.
• CW175

  EUDAMED did not publish a description for this code.
• CW422

  EUDAMED did not publish a description for this code.
• CW401

  EUDAMED did not publish a description for this code.
• CW290

  EUDAMED did not publish a description for this code.

Primary placement in Finland; available across 1 country total.

Placed on the market in Finland; per-country availability dates not published.

Trade name

not provided

UDI-DI code

06438172401075

Basic UDI-DI

B-06438172401075

Reference / catalog number

3467705

Issuing entity

GS1

Risk category

IVDD — General

Applicable legislation

IVDD [Directive 98/79/EC on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

NeoMass CAH Mobile Phase B is an accessory kit component of Labsystems Diagnostics’ NeoMass CAH Kit (Order No: 7150022) to be used for the detection of Congenital Adrenal Hyperplasia (CAH) in newborns.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• W01019099CLINICAL CHEMISTRY REAGENTS - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification